← Back to Search

SUPPORT online platform for people with type 1 diabetes for Diabetes Mellitus (SUPPORT Trial)

N/A
Waitlist Available
Led By Anne-Sophie Brazeau, PhD
Research Sponsored by McGill University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6-month, and 12-month
Awards & highlights

SUPPORT Trial Summary

This trial will test a web-based training platform to see if it is more effective than the current system in teaching people with type 1 diabetes how to use new therapies and technologies to reduce the fear and frequency of hypoglycemia.

Eligible Conditions
  • Type 1 Diabetes Mellitus With Hypoglycemia

SUPPORT Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6-month, and 12-month
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6-month, and 12-month for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Users' satisfaction of the SUPPORT platform
Secondary outcome measures
Change in the frequency and the fear of hypoglycemia
Change in the glycated hemoglobin
Knowledge about diabetes self-management
+1 more

SUPPORT Trial Design

1Treatment groups
Experimental Treatment
Group I: InterventionExperimental Treatment1 Intervention
The intervention group will have immediate access to the SUPPORT platform.

Find a Location

Who is running the clinical trial?

McGill UniversityLead Sponsor
394 Previous Clinical Trials
998,106 Total Patients Enrolled
23 Trials studying Diabetes Mellitus
783,555 Patients Enrolled for Diabetes Mellitus
Institut de Recherches Cliniques de MontrealOTHER
70 Previous Clinical Trials
10,093 Total Patients Enrolled
40 Trials studying Diabetes Mellitus
8,485 Patients Enrolled for Diabetes Mellitus
Canadian Institutes of Health Research (CIHR)OTHER_GOV
1,341 Previous Clinical Trials
26,452,438 Total Patients Enrolled
53 Trials studying Diabetes Mellitus
2,302,274 Patients Enrolled for Diabetes Mellitus

Media Library

SUPPORT Online Training Platform Clinical Trial Eligibility Overview. Trial Name: NCT04233138 — N/A
Diabetes Mellitus Research Study Groups: Intervention
Diabetes Mellitus Clinical Trial 2023: SUPPORT Online Training Platform Highlights & Side Effects. Trial Name: NCT04233138 — N/A
SUPPORT Online Training Platform 2023 Treatment Timeline for Medical Study. Trial Name: NCT04233138 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is it still possible for participants to sign up for this research endeavor?

"Current records on clinicaltrials.gov are suggesting that this study is not presently admitting applicants, despite first being published in February 5th 2020 and last updated 6 months ago. Fortunately, there are still 1299 other medical trials actively seeking participants."

Answered by AI

What aims is this research endeavor attempting to accomplish?

"The primary goal of the trial, which is to be evaluated after 6 months in duration, will assess patient's fear of hypoglycemia. Assessing secondary objectives include: measuring participants' knowledge about diabetes self-management via an online questionnaire; quantifying dietary behaviours including frequency of snacks for physical activity and number consumed for hypoglycemia prevention; and counting the amount nocturnal hypoglycemic episodes endured by patients during a single month."

Answered by AI
~53 spots leftby Apr 2025